Duk-Woo Park

TL;DR: In a cohort of patients with unprotected left main coronary artery disease, there was no significant difference in rates of death or of the composite end point of death, Q-wave myocardial infarction, or stroke between patients receiving stents and those undergoing CABG, but stenting, even with drug-eluting stents, was associated with higher rates of target-vessel revascularization than was CABGs.

TL;DR: Stent thrombosis occurred in 0.8% after DES implantation during long-term follow-up, similar to that for bare metal stents, and independent predictors were premature antiplatelet therapy interruption, primary stenting in acute myocardial infarction, and total stent length.

TL;DR: Elective stenting with IVUS guidance, especially in the placement of drug-eluting stent, may reduce the long-term mortality rate for unprotected left main coronary artery stenosis when compared with conventional angiography guidance.

TL;DR: The use of dual antiplatelet therapy for a period longer than 12 months in patients who had received drug-eluting stents was not significantly more effective than aspirin monotherapy in reducing the rate of myocardial infarction or death from cardiac causes.

TL;DR: Among patients with multivessel coronary artery disease, the rate of major adverse cardiovascular events was higher among those who had undergone PCI with the use of everolimus-eluting stents than among thoseWho had undergone CABG.